Show simple item record

dc.contributor.authorBanerjee, S
dc.contributor.authorLewsley, LA
dc.contributor.authorClamp, Andrew R
dc.contributor.authorKrell, J
dc.contributor.authorHerbertson, R
dc.contributor.authorGlasspool, RM
dc.contributor.authorOrbegoso, C
dc.contributor.authorGreen, C
dc.contributor.authorKristeleit, RS
dc.contributor.authorGourley, C
dc.contributor.authorCambell, C
dc.contributor.authorBanerji, U
dc.contributor.authorShepherd, C
dc.contributor.authorBrugger, W
dc.contributor.authorChudleigh, L
dc.contributor.authorHanif, A
dc.contributor.authorMcNeish, IA
dc.contributor.authorPaul, J
dc.date.accessioned2019-12-09T17:23:30Z
dc.date.available2019-12-09T17:23:30Z
dc.date.issued2019en
dc.identifier.citationBanerjee S, Lewsley LA, Clamp AR, krell J, Herbertson R, Glasspool RM, et al. 993O OCTOPUS: A randomised, multi-centre phase II umbrella trial of weekly paclitaxel+/- novel agents in platinum-resistant ovarian cancer: Vistusertib. Annals of Oncology. 2019;30(Supplement_5):403.en
dc.identifier.doi10.1093/annonc/mdz250.001en
dc.identifier.urihttp://hdl.handle.net/10541/622588
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1093/annonc/mdz250.001en
dc.titleOCTOPUS: A randomised, multi-centre phase II umbrella trial of weekly paclitaxel plus /- novel agents in platinum-resistant ovarian cancer: Vistusertiben
dc.typeMeetings and Proceedingsen
dc.contributor.departmentGynaecology Department, Royal Marsden Hospital NHS Foundation Trust, Londonen
dc.identifier.journalAnnals of Oncologyen
refterms.dateFOA2020-01-21T20:01:54Z


Files in this item

Thumbnail
Name:
mdz250.001.pdf
Size:
108.1Kb
Format:
PDF
Description:
From UNPAYWALL. Conference abstract

This item appears in the following Collection(s)

Show simple item record